Method for the treatment of acute inflammatory diseases of uterus

 

(57) Abstract:

The invention relates to medicine, namely to the gynecologist, in particular to methods of treatment of acute inflammatory diseases of uterus and appendages. To improve the effectiveness of the treatment method involves intensive therapy with broad-spectrum antibiotics within 4 days in combination with treatment with sorbent SUMS-1 in the form of vaginal balls of sorbent on lanolin base that daily enter 1 thing in the posterior vaginal vault within 10 days. 2 C.p. f-crystals.

The invention relates to medicine, namely to the gynecologist, in particular to methods of treatment of acute inflammatory diseases.

There are methods of treatment of inflammatory diseases of uterine appendages, adnexitis, salpingitis and other inflammatory diseases of internal genital organs of women. Usually they are all based on the use of antibiotics, intravenously or orally administered.

The disadvantages of these methods is that antibiotics have side effects: the use of clindamycin, for example, can lead to pseudomembranous colitis.

The closest solution is sceptical, namely kontrikala dissolved in 200-400 ml of sodium chloride solution.

The disadvantage of this method is that this method is effective only in the treatment of inflammatory diseases of uterus, postpartum endometritis, and not its appendages.

The objective of the invention is to increase the efficiency of treatment by providing treatment options simultaneously inflammatory diseases of the uterus and appendages.

The method is as follows.

On the background of complex treatment with antibiotics, physiotherapy, infusion therapy included treatment with sorbent SUMS-1. Vaginal balls of sorbent (30-35%) in lanolin base (the rest) daily enter 1 thing in the posterior vaginal vault within 10 days.

Example. Patient U. 18 years of age, was admitted to the gynecological Department of the Central Clinical hospital of RAS 7.04.93, with a diagnosis of acute metroendometrit, bilateral adnexitis". A serious condition. Complaints at admission: dull pain in the lower abdomen, malaise, headache, weakness, lack of appetite, paleness of skin, tachycardia, shortness of breath, persistent increase in temperature up to 39.5oC.

Blood counts during post what I therapy within 4 days including broad-spectrum antibiotics, fluid therapy (gemodez, reopoliglyukin, glucose, albumin), physical therapy proved ineffective. In addition to therapy included treatment with sorbent SUMS-1. Used vaginal balls of sorbent (30-35%) in lanolin base (the rest). Daily was administered for 1 ball in the back vault of the vagina for 10 days. After 2 days of starting treatment adsorbent began outflow of pus from the vagina, the overall condition has improved; the temperature dropped to 37,3oC. blood counts after 7 days normalized: 5 th, ESR 8 mm/HR After another 2 weeks the patient was discharged from hospital in satisfactory condition.

The proposed method was more effective due to the possibility of treatment of inflammatory diseases, not only cancer, but also appendages, while at a known method of removing endotoxin by the introduction of antiseptics (prototype) treated only inflammatory disease of the uterus.

1. Method for the treatment of acute inflammatory diseases of the uterus through the introduction of antibiotics combined with intracavitary the administration of a medicinal product, characterized in that as lekarstvennoj the low carbon film.

2. The method according to p. 1, characterized in that the above sorbent used in the form of balls, including 30 to 35% of the sorbent and lanolin base the rest.

3. The method according to p. 1, characterized in that the sorbent is injected into the posterior vaginal vault 1 ball 1 time per day for 10 days.

 

Same patents:

The invention relates to medicine, in particular to clinical Oncology and radiology, and can be used for the correction of human blood, including intense radiation, chemoradiation and chemotherapy for patients with malignant tumors

The invention relates to methods of producing high purity carbon sorbents based on active carbons and can be used in medicine, pharmacology, as well as in the food industry

The invention relates to medicine, in particular for clinical Oncology, and can be used for the prevention of human blood, including radiation, chemoradiation and chemotherapy for patients with malignant tumors

The invention relates to medicine and can be used to treat food allergies
The invention relates to medicine and the field of diving and can be used to prevent acute external otitis in the Aquaman for a long time in hyperparameters under pressure to 5.1 MPa (500 m) oxygen-helium environment

The invention relates to medicine, in particular the physiology of diving, aviation and space medicine
The invention relates to medicine, more specifically to clinical toxicology, and can be used for the treatment of patients with acute oral poisoning

FIELD: medicine, pharmacy.

SUBSTANCE: invention relates to a pharmaceutical composition used for stabilization of homeostasis and arresting pathological processes in the body. Invention proposes a pharmaceutical composition as powder with particles size from 250 to 400 mcm comprising the following components by the first variant, wt.-%: carbon, 10.01-53.02; oxygen, 30.10-53.10; potassium, 0.26-1.99, and calcium, 0.20-31.37, and comprising the following components by the second variant, wt.-%: calcium, 0.35-31.20; carbon, 10.99-50.21; oxygen, 34.55-51.03; sulfur, 0.73-14.81, and phosphorus, 0.08-3.30. Invention provides compensation of trace elements unbalance that causes and accompanies many diseases, possibility for stabilization of trace element homeostasis and arresting pathological processes of different etiology.

EFFECT: improved and valuable medicinal properties of composition.

12 cl, 13 ex

FIELD: medicine, pharmacy.

SUBSTANCE: invention relates to preparing medicinal and biologically active substances that can be used for carrying out the supporting therapy. Agent for supporting therapy comprises ultradispersed diamonds or nanodiamonds in the concentration 10-9-10-10 g/kg of the preparation providing the enhancement of activity of preparation of the natural origin and synthesized artificially and used in treatment and prophylaxis of diseases. Invention provides enhancing effect of medicinal agents.

EFFECT: enhanced and valuable medicinal properties of agent.

3 ex

FIELD: medicine, endocrinology, surgery.

SUBSTANCE: it is necessary to perform intra-pelvic novocain-antibacterial blockade by a certain technique at keeping a catheter in pelvic fiber for further prolonged novocain-antibacterial blockade, then it is necessary to fulfill necrectomy and lance purulent congestions followed by treating with VIER in flow-aerosol mode and application of a sorbent OUT-M till the transition of early wound process into the stage of proliferation; in case of dressing procedure one should apply prolonged intra-pelvic novocain-antibacterial blockade; after transition of early wound process into the stage of proliferation one should treat the wound with VIER in aerosol mode till application of the secondary sutures. The present innovation enables to remove degenerated substances from wound surface very quickly, improve microhemodynamics and lymphodynamics that, in its turn, favors rapid transition of wound process into the stage of proliferation and, thus, the quickest wound healing.

EFFECT: higher efficiency of therapy.

2 cl, 1 ex

FIELD: medicine and medical chemistry, in particular treatment of exo- and endogenous intoxication.

SUBSTANCE: hemosorbent is treated with 0.005 N potassium permanganate solution; wherein sulfuric acid is used to produce acidic medium. Before heat treatment liquid phase is removed, heat treatment is carried out for 10 min, then hemosorbent is cooled, washed with distilled water and dried in air.

EFFECT: detoxication process of increased effectiveness; treatment with reduced time and cost.

3 ex, 4 tbl, 1 dwg

FIELD: biology and medicine, in particular therapy of viral and tumor diseases.

SUBSTANCE: claimed method includes exposing of viruses or cells with siglet oxygen generating from molecular oxygen by using of carbon photosensitizing agent contacting with molecular oxygen and said viruses or cells and irradiating with optical radiation. As photosensitizing agent slurry of polyhedral layered carbon nanostructures having interlaminar distances of 0.34-0.36 nm are used.

EFFECT: nanostructures with high heat and radiation resistance, precipitation resistance and relatively low cost.

10 cl, 3 ex

FIELD: pharmaceutical industry.

SUBSTANCE: claimed adsorbent contains spherical active carbon, obtained from thermosetting resin as carbon source, having particle size of 0.001-1 mm, specific surface determined by Langmuir adsorption equation of 1000 m2/g or more and pore volume of 7.5-15000 nm in diameter less than 0.25 ml/g. Also disclosed is adsorbent being similar to abovementioned one, wherein total content of acidic groups is 0.40-1.00 meq/g; total content of basic groups is 0.4-1.1 meq/g. Pharmaceutical compositions contain said adsorbents and pharmaceutically acceptable carriers and recipients. Agents of present invention are useful in treatment of kidney or liver diseases or disorders associated with uremic substance by administration of said adsorbents.

EFFECT: products of increased selectivity.

21 cl, 5 ex, 2 tbl, 11 dwg

FIELD: medicine.

SUBSTANCE: claimed adsorbent contains spherical activated carbon having size diameter of 0.01-1 mm, specific surface determined in accordance to Langmuir equation of 1000 m2/g or more, ratio of diffraction intensities R of 1.4 or more (R is determined as R = (I15-I35)/(I24-I35) (1), wherein I15 is diffraction intensity at diffraction angle (2θ) of X-ray diffraction is 15°C; I35 is diffraction intensity at diffraction angle (2θ) of X-ray diffraction is 35°C; I24 is diffraction intensity at diffraction angle (2θ) of X-ray diffraction is 24°C), and pore volume having diameter of 7.5-15000 nm is less than 0.25 mg/ml. In another embodiment claimed adsorbent contains abovementioned spherical activated carbon with modified surface. Also disclosed are pharmaceutical composition and method for prevention or treatment of kidney or liver diseases containing said adsorbent.

EFFECT: new adsorbent for peroral administration.

20 cl, 5 ex, 2 tbl, 12 dwg

FIELD: medicine.

SUBSTANCE: method involves aqueous mineral solution inhalations. The solution is prepared by drawing shungit on mineral water. Inhalation is carried out with solution temperature of 20-24°C within 10 min every day during 7-14 days.

EFFECT: enhanced effectiveness of treatment; reduced treatment cost.

FIELD: chemistry.

SUBSTANCE: carbonic mesoporous hemosorbent in the form of smoothed granules of the pseudo-spherical form is proposed. They consist of nano-dispersed of a carbon-carbon material in the form of a three-dimensional matrix, formed curved by layers of carbon of thickness 30-400 Å with radius of curvature 100-1600 Å, interplanar spacing of the layers of carbon is 3.48-3.60 Å which contains not less than 99.5% of carbon, and has density by helium of 1.80-2.08 g/cm3, iodine number 175-245 mg/g, on a specific area on BET 300-400 m2/g, the strength of granules during abrasion is not more than 0.30%/min, total volume of pores not less than 0.4 cm3/g, average diameter mesopore 4.0-20.0 nanometers, it is characterised by the fact that hemosorbent contains granules with the size of 0.3-1.0 mm, and the quantity of granules in the size of 0.3-0.5 mm makes 11-45%, and the content of ashes is no more than 0.08%. Hemosorbent possesses high chemical cleanliness, high mechanical durability of granules, smoothed surface of granules and absence of a dust that gives to it increased blood-compatibility and inertness in relation to the regular elements of blood and provides good dynamics of the sorption cleaning, and prevailing presence mesopore and transitional pores provide a high degree of cleaning blood from low and medium molecular toxins.

EFFECT: hemosorbent has high resistance to sterilisation; is nontoxic and is apyrogenous

3 ex, 1 tbl, 2 dwg

FIELD: medicine; cardiology.

SUBSTANCE: method involves long-term individual hypocalorific diet, sensibly graded static and dynamic physical activity, administration of metformin by 500 mg twice per day after meals, essentiale forte by 1 capsule three times per day, tocopherol acetate by 0.1 g twice per day, and activated coal by 1 pill per 10 kg of weight by night.

EFFECT: bringing biological and chronological age of patients with metabolic syndrome.

2 ex, 1 dwg

Up!